Mealey’s™ Merck & Co., Inc.'s VIOXX® Settlement Conference: A Plaintiff Bar Discussion & Roundtable to be held Dec. 10 in New Orleans

On November 9th, Merck & Co. Inc. announced that they would pay $4.85 billion to settle product liability claims related to usage of VIOXX, its arthritis and acute pain medication that was removed from the market in 2004. These funds will be used to resolve VIOXX-related claims involving plaintiffs who suffered a heart attack or a stroke and represents the largest pharmaceutical settlement in history.

MORE ON THIS TOPIC